(XCS7) Xtrackers MSCI China 1D - Ratings and Ratios
Chinese, Stocks, Equity, Investments, China
Description: XCS7 Xtrackers MSCI China 1D
The Xtrackers MSCI China UCITS ETF 1D EUR (XETRA:XCS7) is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing investors with exposure to the Chinese equity market. As a Germany-originated ETF, it is listed on the XETRA exchange and falls under the China Equity category.
From a technical standpoint, the ETF has shown a relatively stable trend, with its short-term and long-term moving averages indicating a gradual upward trajectory. The current price of 8.04 is slightly above its 20-day simple moving average (SMA) of 8.01, suggesting a potential continuation of the uptrend. The 50-day SMA at 7.82 and 200-day SMA at 7.66 provide further support for this notion, as the price has consistently been trading above these levels. The average true range (ATR) of 0.12, representing 1.52% of the current price, indicates moderate volatility. Given the current technical setup, a potential price target could be the 52-week high of 8.97, with a stop-loss around 7.66 to limit potential losses.
Fundamentally, the ETF has a substantial assets under management (AUM) of 1833.33M EUR, indicating a significant investor base and liquidity. This, combined with the growing importance of the Chinese equity market, positions the ETF for potential long-term growth. As the Chinese economy continues to evolve and expand, the ETF is likely to benefit from the increasing market capitalization of its underlying constituents.
Forecasting the ETFs future performance, we can expect a continued upward trend, driven by the technical indicators and fundamental strengths. Assuming the current trend persists, the ETF may reach the 52-week high of 8.97 in the near term. However, its essential to monitor the ATR and adjust the investment strategy accordingly to manage potential risks. In the long term, the ETFs AUM and the growing Chinese equity market are likely to drive further growth, potentially pushing the price beyond the current 52-week high.
Additional Sources for XCS7 ETF
XCS7 ETF Overview
Market Cap in USD | 2,160m |
Category | China Equity |
IPO / Inception | 2022-04-20 |
XCS7 ETF Ratings
Growth Rating | 24.2 |
Fundamental | - |
Dividend Rating | 10.0 |
Rel. Strength | -4.09 |
Analysts | - |
Fair Price Momentum | 7.29 EUR |
Fair Price DCF | - |
XCS7 Dividends
Dividend Yield 12m | 2.10% |
Yield on Cost 5y | 2.41% |
Annual Growth 5y | -14.81% |
Payout Consistency | 89.7% |
Payout Ratio | % |
XCS7 Growth Ratios
Growth Correlation 3m | 43.5% |
Growth Correlation 12m | 70.6% |
Growth Correlation 5y | 11.9% |
CAGR 5y | 5.39% |
CAGR/Max DD 5y | 0.15 |
Sharpe Ratio 12m | -0.08 |
Alpha | 12.47 |
Beta | 0.569 |
Volatility | 98.37% |
Current Volume | 67.8k |
Average Volume 20d | 5.4k |
Stop Loss | 7.7 (-3.3%) |
As of July 09, 2025, the stock is trading at EUR 7.96 with a total of 67,830 shares traded.
Over the past week, the price has changed by +0.82%, over one month by -2.09%, over three months by +10.98% and over the past year by +25.04%.
Neither. Based on ValueRay´s Analyses, Xtrackers MSCI China 1D is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.23 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XCS7 is around 7.29 EUR . This means that XCS7 is currently overvalued and has a potential downside of -8.42%.
Xtrackers MSCI China 1D has no consensus analysts rating.
According to our own proprietary Forecast Model, XCS7 Xtrackers MSCI China 1D will be worth about 8.2 in July 2026. The stock is currently trading at 7.96. This means that the stock has a potential upside of +3.52%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 8.2 | 3.5% |